Live Breaking News & Updates on Biomarin Pharmaceutical Fourth Quarter

BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44. ....

United States , Greg Guyer , Salveen Richter , Alexander Hardy , Jeff Ajer , Jessica Fye , Henry Fuchs , Akash Tewari , Traci Mccarty , Hank Fuchs , Brian Mueller , Goldman Sachs , Biomarin Pharmaceutical Inc , Biomarin Pharmaceutical , Call Transcript February , Marin Pharmaceutical , Biomarin Pharmaceutical Fourth Quarter , Full Year , Investor Relations , Chief Executive Officer , Executive Vice President , Chief Financial Officer , Chief Commercial Officer , Chief Technical Officer , Investor Day , Pediatric Endocrine Society Meeting ,